Cogentix Medical (CGNT) Misses Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Cogentix Medical Reports 83% Second Quarter Revenue Growth
November 3, 2015 4:01 PM ESTMINNEAPOLIS, Nov. 3, 2015 /PRNewswire/ -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today announced results for the fiscal second quarter ended September 30, 2015.
Second Quarter Fiscal 2016 Overview
Revenue of $11.8 million increased 83% from $6.5 million reported in the year-ago period (86% on a constant currency basis) Revenue of $11.8 million increased 12% from the pro forma combined revenue of Uroplasty and Vision-Sciences in the same period last year (14% on a constant currency basis) U.S.... More